What is Electronic Waveform Lab?
Founded in 1981, Electronic Waveform Lab specializes in the development and production of the H-Wave, a sophisticated multi-functional electrical stimulation device. The technology is engineered to facilitate accelerated recovery, restore physiological function, and provide comprehensive management for chronic, acute, and post-operative pain. By maintaining a focus on non-invasive therapeutic solutions, the company has established a durable footprint in the medical device industry, leveraging decades of clinical application to refine its product efficacy and market reach. The firm operates at the intersection of pain management and rehabilitation technology, serving a diverse patient demographic through its specialized hardware.
How much funding has Electronic Waveform Lab raised?
Electronic Waveform Lab has raised a total of $4M across 2 funding rounds:
Debt
$2M
Debt
$2M
Debt (2020): $2M with participation from PPP
Debt (2021): $2M led by PPP
Key Investors in Electronic Waveform Lab
PPP
Public-Private Partnership
What's next for Electronic Waveform Lab?
With the recent influx of capital, Electronic Waveform Lab is positioned to accelerate its enterprise-level growth initiatives. The strategic deployment of these funds will likely focus on expanding manufacturing capacity, enhancing research and development pipelines for next-generation stimulation devices, and strengthening market penetration within clinical settings. As the healthcare landscape shifts toward more integrated, technology-driven pain management protocols, the company is well-equipped to leverage its long-standing operational history to capture additional market share. Future growth trajectories will likely prioritize the scaling of distribution networks and the pursuit of broader regulatory approvals to support the continued adoption of the H-Wave platform in both domestic and international markets.
See full Electronic Waveform Lab company page
